SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-23-052978
Filing Date
2023-04-28
Accepted
2023-04-28 16:15:50
Documents
14
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2313884d1_10ka.htm   iXBRL 10-K/A 372946
2 EXHIBIT 31.3 tm2313884d1_ex31-3.htm EX-31.3 4998
3 EXHIBIT 31.4 tm2313884d1_ex31-4.htm EX-31.4 5028
  Complete submission text file 0001104659-23-052978.txt   652811

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aptx-20221231.xsd EX-101.SCH 3030
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aptx-20221231_lab.xml EX-101.LAB 36509
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aptx-20221231_pre.xml EX-101.PRE 23996
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2313884d1_10ka_htm.xml XML 5728
Mailing Address 909 DAVIS STREET SUITE 600 EVANSTON IL 60201
Business Address 1801 MAPLE AVENUE SUITE 4300 EVANSTON IL 60201 847-871-0377
Aptinyx Inc. (Filer) CIK: 0001674365 (see all company filings)

IRS No.: 474626057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38535 | Film No.: 23866427
SIC: 2834 Pharmaceutical Preparations